Benzinga's Top Pre-Market Gainers

VIVUS Inc VVUS surged 105.50% to $21.68 in the pre-market session. VIVUS reported that the US Food and Drug Administration Advisory Committee recommended approval of Qnexa for the treatment of obesity in adults. Orexigen Therapeutics Inc OREX added 23.68% to $3.97 in the pre-market session. OREX shares have dropped 1.23% over the past 52 weeks, while the S&P 500 index has gained 4.30% in the same period. Arena Pharmaceuticals Inc ARNA moved up 18.23% to $2.14 in the pre-market session. ARNA is scheduled to present at the Citi 2012 Global Health Care Conference on February 29. Spanish Broadcasting System Inc SBSA soared 6.04% to $6.14 in the pre-market trading. SBSA's trailing-twelve-month ROE is 43.22%.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPre-Market OutlookMarketsMoversTop Pre-Market Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!